Breadcrumbs Home Investors Press Releases Press Releases Press Releases Regulatory Press Releases More Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2018-05-15 20:00Bulletin from Moberg Pharma's AGM 2018Read more 2018-05-08 08:00Moberg Pharma AB Interim report January - March 2018Read more 2018-05-02 08:30U.S. patent granted for BUPIRead more 2018-04-27 08:30Moberg Pharma completes divestment of Balmex® for $4.25 millionRead more 2018-04-26 08:00Moberg Pharma's report for the first quarter to be published on May 8 - Invitation to teleconferenceRead more 2018-04-19 09:30Management change in Moberg PharmaRead more Pagination First page Previous page … Page 33 Page 34 Page 35 Page 36 Current page 37 Page 38 Page 39 Page 40 Page 41 … Next page Last page Press Releases Data Year20262025202420232022202120202019201820172016201520142013201220112010 2016-10-19 08:30European Patent granted for BUPIRead more 2016-09-28 08:30Moberg Pharma begins patient enrollment in North America and Europe in two Phase 3 studies of MOB-015 in onychomycosisRead more 2016-08-10 08:30Moberg Pharma announces approvals to start Phase 3 study for MOB-015 in U.S. and CanadaRead more 2016-08-09 08:00Moberg Pharma AB Interim Report January - June 2016Read more 2016-07-08 08:30Moberg Pharma completes acquisition of U.S. OTC brands from Prestige BrandsRead more 2016-06-30 15:30Moberg Pharma completes tap issue of SEK 85mRead more Pagination First page Previous page … Page 33 Page 34 Page 35 Page 36 Current page 37 Page 38 Page 39 Page 40 Page 41 … Next page Last page
